Viruses, Pandemics, and Immunity

Home > Other > Viruses, Pandemics, and Immunity > Page 18
Viruses, Pandemics, and Immunity Page 18

by Arup K. Chakraborty


  viral entry and, 45, 137–142

  Spirits, demons, and divine punishment, 2–3

  Spontaneous generation theory, 28

  Starkloff, Max, 119–121

  St. Louis during 1918 influenza pandemic, 119–121

  Subunit vaccines, 159–162

  Surveillance, ongoing, 182–183

  Sweden, COVID-19 in, 128–129

  Swine flu pandemic (2009), 61

  T-cell receptor (TCR), 88–89, 92, 99

  T cells (T lymphocytes), 154

  adaptive immune system and, 85, 87–90, 91f, 92–93

  antibodies and, 89, 99, 155

  B cells and, 88, 89, 99

  cytokines and, 93, 96, 99

  drugs and, 89, 90

  genes and, 87–90

  HLA and, 87–88, 90, 91f, 92–93, 99, 154, 177

  killer, 93, 99, 154–156, 178

  nature of, 85, 87, 92

  peptides and, 90, 92

  proteins and, 92, 99

  thymus and, 87, 92

  vaccines and, 101, 155–157, 159, 174, 178

  viruses and, 85, 87, 88, 91f, 92–93, 99–101, 136, 138, 154–157, 160, 174, 177, 178

  Temin, Howard, 48

  Thymus, 86, 87, 92

  Toll-like receptors, 95

  Tonegawa, Susumu, 77

  Toussaint, Jean Joseph Henri, 32

  Transmissibility. See Basic reproductive number

  Transmission, community. See Community spread

  Transplantation, organ, 86–87

  Tuberculosis (TB), 24–25, 35

  Tumor necrosis factor (TNF), 95

  Unanue, Emil, 89–90

  United Kingdom, 128. See also British royal family

  Urbani, Carlo, 104, 115

  Vaccination. See also specific topics

  goal of, 155

  a new paradigm for, 29–33

  Pasteur and, 15, 29–33, 35, 157

  origin of the term, 13, 15

  Vaccine candidates, clinical trials of, 164–167

  phases in, 164–167, 169–170, 175

  Vaccine development

  discovery phase, 164

  examples of, 167–179

  Vaccines, 183–185. See also specific topics

  how they work, 154–156

  spike proteins and, 154, 155, 159–161, 174, 175, 177

  types of

  DNA and RNA vaccines, 162–164

  killed or inactivated vaccines, 158–159

  live attenuated vaccines, 30–31, 156–159, 169, 171, 172 (see also Variolation)

  subunit vaccines, 159–162

  and viral replication, 161–162

  Vaccine safety, 178–180

  Van Leeuwenhoek, Antonie Philips, 20–22

  microscope, 20, 21f

  Variolation

  British Royal Society and, 8–9

  cowpox and, 11, 12, 157

  dangers, 157

  history of, 8–10, 15

  variolation replaced by vaccination, 15

  Jenner and, 11–12

  procedure, 11, 157

  safety, 13, 157, 179

  smallpox, 9–11, 29–30, 157

  used by British royal family, 9, 10, 179

  Vectors, viral, 162, 173, 174

  Vietnam, 116. See also Urbani, Carlo

  Viral entry

  blocking, 139–142

  spike proteins and, 45, 137–142

  Viral replication, 36–39, 44, 137

  blocking, 142–143, 144f, 145, 154, 161–162

  antiviral drugs for, 136, 137, 142, 143, 145, 148, 149

  interferons, 96–98

  in DNA viruses, 46, 143

  fever and, 96

  genome and, 138, 142, 143

  in HIV, 145, 177

  and mutation, 148 (see also Mutations)

  in retroviruses, 48

  in RNA viruses, 46–48, 142

  spike proteins and, 45

  vaccines and, 161–162

  viruses need (human) host for, 44–49

  Viral vectors, 162, 173, 174

  Virulence. See Basic reproductive number

  Viruses, 46. See also specific topics

  how they enter our cells, 45

  identifying, 136–137

  out eternal war with, 36–39

  types of, 45–49

  Von Behring, Emil, 70–71

  Weather and virus spread, 59, 109

  “Weathering the storm,” 123–130

  social distancing and, 123, 124, 128, 130

  Weller, Thomas, 136, 169

  Wiley, Donald, 90

  World War I, xii, 120

  Wuhan, China, 52, 57, 116, 117, 122–123

  Yellow fever, 155–156

  Yersinia pestis, xii. See also Bubonic plague

  Zika virus epidemic of 2015–2016, 128, 174

  Zinkernagel, Rolf M., 87–90, 92

 

 

 


‹ Prev